Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis

Oral Oncology

Volumn 47, Issue 5, 2011, Pages 365-370

  Tang, Qiong Lan ^a   Fan, Song ^a   Li, Hai Gang ^a   Chen, Wei Liang ^a   Shen, Xi Ming ^a   Yuan, Xiao Ping ^a   Chang, Shao Hai ^a   Song, Yang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Clinicopathological features; Cyr61; Ki 67; Prognosis; Salivary adenoid cystic carcinoma

Indexed keywords

CYSTEINE RICH PROTEIN 61; FLUOROURACIL; KI 67 ANTIGEN; METHOTREXATE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; SOLID TUMOR;

ADULT; CARCINOMA, ADENOID CYSTIC; CHINA; CYSTEINE-RICH PROTEIN 61; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS;

EID: 79956219892     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.02.022     Document Type: Article

References (21)

1. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours: pathology and genetics of head and neck tumours, vol 9. Lyon: IARC Press; 2005. p. 221-2.
2. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006;42:759-69. (Pubitemid 44307768)
3. Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 2009;41:771-83.
4. Mönckedieck V, Sannecke C, Husen B, et al. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model. Mol Hum Reprod 2009;15:633-43.
5. Tsai MS, Bogart DF, Castañeda JM, et al. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002;21:8178-85. (Pubitemid 35454421)
6. Xie D, Yin D, Wang HJ, et al. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 2004;10:2072-81. (Pubitemid 38375569)
7. Tang QL, Liu WP, Zhang WY, et al. Expression of CYR61 and VEGF in extranodal nasal-type NK/T cell lymphoma and their significances. Zhong Hua Xue Ye Xue Za Zhi 2006;27:661-5.
8. Xie JJ, Xu LY, Wu JY, et al. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 2010;176:939-51.
9. Allison RT, Best T. P53, PCNA, and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med 1998;27:434-40. (Pubitemid 28490132)
10. Lim JJ, Kang S, Lee MR, et al. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 2003;32:552-61. (Pubitemid 37175008)
11. Sobin LH, Gospodarowicz MK, Wittekind CH. International Union against Cancer (UICC), TNM Classification of Malignant Tumours. Chichester: Blackwell Publishing Ltd.; 2010. p. 22-57.
12. Zhou ZQ, Cao WH, Xie JJ, et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009;9:291-8.
13. Liu L, Cai YL, Lv Y, et al. Expression and significance of EGFR in salivary gland adenoid cystic carcinoma. J Oral Maxillofac Surg 2007;17:320-3.
14. Vargas PA, Cheng Y, Barrett AW, et al. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med 2008;37:309-18. (Pubitemid 351533536)
15. Su JL, Chiou J, Tang CH, et al. CYR61 regulates BMP-2-dependent osteoblast differentiation through the αvγ3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem 2010;285:31325-36.
16. Vellon L, Menendez JA, Lupu R. αvγ3 integrin regulates heregulin (HRG)- induced cell proliferation and survival in breast cancer. Oncogene 2005;24:3759-73. (Pubitemid 40826875)
17. Lin MT, Chang CC, Chen ST, et al. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-κB-dependent XIAP up-regulation. J Biol Chem 2004;279:24015-23.
18. Lin MT, Zuon CY, Chang CC, et al. Cyr61 induces gastric cancer cell motility/ invasion via activation of the integrin/nuclear factor-κB/ cyclooxygenase-2 signaling pathway. Clin Cancer Res 2005;11:5809-20.
19. Xie D, Nakachi K, Wang H, et al. Elevated levels of connective tissue growth factor, WISP-1, and Cyr61 in primary breast cancers associated with more advanced features. Cancer Res 2001;61:8917-23.
20. Kok SH, Chang HH, Tsai JY, et al. Expression of Cyr61 (CCN1) in human oral squamous cell carcinoma: an independent marker for poor prognosis. Head Neck 2010;32:1665-73.
21. Menendez JA, Vellon L, Mehmi I, et al. A novel CYR61-triggered 'CYR61-αvγ3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 2005;24:761-79.